Novel Antibodies Drug Conjugate (Cell Therapy) Equipment
2 equipment items found
-
based in SWITZERLAND
CIS Pharma develops novel antibody-drug- conjugates (ADCs) based on our proprietary polymer carrier platform. Our polymers serve as carriers that are loaded with cytotoxic drugs, radioisotopes or other active entities. The carrier together with its cargo is conjugated to a target-specific ...
-
Manufactured by Araris Biotech AGbased in SWITZERLAND
Araris Biotech AG, a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich, is pioneering the development of a novel, proprietary antibody-drug conjugate (ADC)-linker technology. Our linker platform enables payload attachment to ‘off-the-shelf’ antibodies in one step without needing ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you